CervoMed (CRVO) Net Margin (2023 - 2025)
Historic Net Margin for CervoMed (CRVO) over the last 9 years, with Q3 2025 value amounting to 2394.96%.
- CervoMed's Net Margin fell 21499000.0% to 2394.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 415.21%, marking a year-over-year decrease of 2965400.0%. This contributed to the annual value of 167.28% for FY2024, which is 610000.0% down from last year.
- Per CervoMed's latest filing, its Net Margin stood at 2394.96% for Q3 2025, which was down 21499000.0% from 355.47% recorded in Q2 2025.
- Over the past 5 years, CervoMed's Net Margin peaked at 70.44% during Q2 2024, and registered a low of 2394.96% during Q3 2025.
- Over the past 3 years, CervoMed's median Net Margin value was 172.15% (recorded in 2023), while the average stood at 379.54%.
- Per our database at Business Quant, CervoMed's Net Margin surged by 1100bps in 2024 and then tumbled by -21499000bps in 2025.
- Quarter analysis of 3 years shows CervoMed's Net Margin stood at 94.83% in 2023, then tumbled by -227bps to 310.3% in 2024, then tumbled by -672bps to 2394.96% in 2025.
- Its last three reported values are 2394.96% in Q3 2025, 355.47% for Q2 2025, and 255.22% during Q1 2025.